We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Corbus Pharmaceuticals announced a restructuring of its workforce designed to reallocate capital to certain clinical and preclinical programs. The restructuring will result in a reduction of its workforce by 54%.
Amneal Pharmaceuticals has announced a restructuring plan designed to reduce its cost base to and optimize its global manufacturing infrastructure. The company did not specify if the restructuring would include employee layoffs.
The Bayer Group is restructuring its core life science businesses through a series of portfolio, efficiency and structural measures that will result in the reduction of approximately 12,000 jobs worldwide...
Now that the struggling drugmaker has recut its guidance, slashed its dividend and cautioned investors that it may breach its debt covenants, “they have to pay more than market,” analysts and investors told The Wall Street Journal.